Blog
Liposomal Doxorubicin Market to Reach USD2.4B by 2035 Driven by Oncology Growth in APAC, Europe
The global liposomal doxorubicin market is projected to expand from USD 1.3 billion in 2025 to USD 2.4 billion by 2035, registering a CAGR of
FMI
November 7, 2025